NASDAQ:OBIO | Cash Flow Statement | Orchestra BioMed Holdings, Inc.

Complete source-backed cash-flow history.

Available history
2020-09-30 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$23.76M
2026-03-31-$20.69M$90,000.00-$22.17M$184,000.00$10.32M$5.53M
2025-12-31$6.25M$82,000.00-$2.27M$33,000.00-$17.71M$12.66M
2025-09-30-$20.83M
2025-06-30-$19.36M
2025-03-31-$18.76M$83,000.00-$16.62M$112,000.00$13M-$296,000.00
2024-12-31-$16.16M$84,000.00-$13.54M$106,000.00-$3.75M$13.95M
2024-09-30-$15.43M
2024-06-30-$15.98M
2024-03-31-$13.46M$74,000.00-$13.11M$8,000.00$5.86M$18,000.00
2023-12-31-$12.82M$72,000.00-$10.97M-$3,000.00$33.15M-$10.7M
2023-09-30-$13.32M
2023-06-30-$12.05M
2023-03-31-$10.94M$71,000.00-$14.38M$35,000.00-$43.53M$56.82M
2022-12-31-$9.75M$70,000.00-$8.74M$54,000.00-$63.38M-$5.09M
2022-09-30-$10.28M
2022-06-30-$7.85M
2022-03-31-$5.73M$48,000.00-$5.32M$47,000.00-$47,000.00$24.76M
2021-12-31-$88,011.00-$28,835.00
2021-09-30-$90,411.00
2021-06-30-$92,329.00
2021-03-31-$108,002.00-$76,374.00
2020-09-30-$66,214.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$52.7M$327,000.00-$48.96M$489,000.00-$26.94M$88.33M
2024-12-31-$61.02M$308,000.00-$50.56M$289,000.00$13.09M$29.17M
2023-12-31-$49.12M$287,000.00-$46.13M$78,000.00$10.69M$46.22M
2022-12-31-$33.61M$222,000.00-$29.29M$591,000.00-$64.12M$103.26M
2021-12-31-$378,753.00-$272,362.00